Johnson & Johnson to Acquire V-Wave
August 21, 2024
August 21, 2024
NEW BRUNSWICK, New Jersey, Aug. 21 (TNSres) -- Johnson and Johnson issued the following news release:
* * *
V-Wave's Novel and Minimally Invasive Interatrial Shunt is Designed to Treat Heart Failure and Addresses Significant Treatment Gap
Device Further Strengthens Johnson & Johnson MedTech's Position in Cardiovascular
* * *
Johnson & Johnson1 (NYSE: JNJ) today announced that it has entered into a definitive agreement to ac . . .
* * *
V-Wave's Novel and Minimally Invasive Interatrial Shunt is Designed to Treat Heart Failure and Addresses Significant Treatment Gap
Device Further Strengthens Johnson & Johnson MedTech's Position in Cardiovascular
* * *
Johnson & Johnson1 (NYSE: JNJ) today announced that it has entered into a definitive agreement to ac . . .